Home
Awards
Events
Features
An author's perspective
Ask the Experts
Conference reports
eBooks
Expert opinion
In the Zone
Journal articles
Journal content
Spotlights
Tech Digest
Follow us on social media
Glossary
Topics
Applications
Advanced therapies
Biomarkers
Clinical
Diagnostics
Drug development
Forensic
Patient-centric sampling
Sports drug testing
Toxicology
Vaccines
Industry updates & regulations
Biopharmaceuticals
Collaborations & mergers
Data processing & interpretation
Regulated bioanalysis
Molecules
Antibodies | ADCs
Biosimilars
Large
Metabolites
Oligonucleotides
Small
Techniques
Automation
Chromatography
Imaging
LBA
Microsampling
MS (LC–MS/MS, HRMS, IMS)
Sample preparation
Follow us on social media
Multimedia
Coffee chats
Infographics
Interviews
Panel discussions
Podcasts
Videos
Webinars
Follow us on social media
News
Partners
Register
Key qualities to ensure success when outsourcing immunogenicity assay development
23 Oct 2019
Biomarkers
Clinical
Diagnostics
Immunogenicity
< Back to – In the Zone: Immunogenicity
Share
Previous article
Next article
Related articles
5 FEB 2020
JOURNAL ARTICLES
Mitigating target interference in bridging immunogenicity assay with target-blocking reagents and mild basic pH
1 OCT 2020
EXPERT OPINION
Peek behind the paper: how ADA methodology informs SARS-CoV-2 assay development
23 MAY 2016
REGULATED BIOANALYSIS
Bioanalytical Specialty Section of Society of Quality Assurance Responds to your Questions
26 FEB 2015
AUTOMATION
Laboratory automation: letting scientists focus on science
1 JUN 2023
NEWS
Coris Bioconcept acquired by Avacta
17 MAY 2016
LARGE
Convergence of LBA/LC–MS in bioanalysis of large molecules – Part 2